Effect of Berberis aristata on lipid profile and coagulation parameters

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 7, 2011, Pages 943-947

  Razzaq, Faiza Abdul ^a   Khan, Rafeeq Alam ^a   Feroz, Zeeshan ^a,b   Afroz, Syeda ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b ZIAUDDIN UNIVERSITY   (Pakistan)

Author keywords

Berberis aristata; Coagulation parameters; Lipid profile

Indexed keywords

ANTILIPEMIC AGENT; BERBERIS ARISTATA EXTRACT; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BERBERIS; BERBERIS ARISTATA; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HYPERLIPIDEMIA; LIPID ANALYSIS; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RABBIT; THROMBIN TIME; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 80051661361     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aghasadeghi K, Zarei-Nezhad M, Keshavarzi A, Mehrabani D (2008). The prevalence of coronary risk factors in Iranian lor migrating tribe. Arch. Iran Med., 11(3): 322-325.
2. Alcaraz MJ, Jimenez MJ (1989). Anti-inflammatory compounds from sideritis Javalambrensis N-hexane extract. J. Nat. Prod., 52: 1088-1091.
3. Ali M, Malik AR, Sharma KR (2008). Vegetative propagation of Berberis aristata DC. An endangered Himalayan shrub. J. Med. Plants Res., 2(12): 374-377.
4. Allen JK, Young DR, Blumenthal RS, Moy TF, Yanek LR, Wilder L, Becker LC, Becker DM (1996). Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease. Arch. Intern. Med., 156(15): 1654-1660.
5. Aoki I, Aoki N, Kawano K, Shimoyama K, Maki A, Homori M, Yanaqisawa A, Yamamoto M, Kawai Y, Ishikawa K (1997). Platelet-Dependent Thrombin Generation in patients with Hyperlipidemia. J. Am. Coll. Cardiol., 30(1): 91-96.
6. Aziz Z, Tey NP (2009). Herbal medicines: Prevalence and predictors of use among Malaysian adults. Complement. Ther. Med., 17(1): 44-50.
7. Chan K, Yin M, Chao W (2007). Effect of diallyl trisulfide-rich garlic oil on blood coagulation and plasma activity of anticoagulation factors in rats. Food Chem. Toxicol., 45: 502-507.
8. Cicero AF, Ertek S (2009). Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. Clin. Lipidol., 4(5): 553-563.
9. Deniz O, Tozkoparan E, Yaman H, Cakir E, Gumus S, Ozcan O, Bozlar U, Bilgi C, Bilgic H, Ekiz K (2006). Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia. Clin. Biochem., 39(3): 287-292.
10. Di Cera E (2008). Thrombin. Mol. Aspects Med., 29: 203-254.
11. Eitzman DT, Westrick RJ, Xu Z, Tyson J, Ginsburg D (2000). Hyperlipidemia Promotes Thrombosis After Injury to Atherosclerotic Vessels in Apolipoprotein E-Deficient Mice. Arterioscl. Throm. Vas., 20(7): 1831-1834.
12. Fang W, Hong-Yi Z, Gang Z, Li-Ying F, Lan C, Jian-Guo C, Wei-Xing Y (2004). Inhibitory effects of berberine on ion channels of rat hepatocytes. World J. Gastroentero., 10(19): 2842-2845.
13. Feroz Z, Khan RA, Afroz S (2009). Effect of multiple drug administration on gross toxicities and electrolytes. Pak. J. Pharmacol., 26(2): 1-7.
14. Feroz Z, khan RA, Mirza T, Afroz S (2010). Adverse effects of cumulative administration of anti-epileptic, anti-hypertensive, antidiabetic, anti-arrhythmic drugs on renal and cardiac parameters. Int. J. Med. Res., 1(1): 39-47.
15. Feroz Z, Khan RA, Afroz S (2011). Cumulative toxicities on lipid profile and glucose following administration of antiepileptic, antihypertensive, antidiabetic and antiarrhythmic drugs. Pak. J. Pharm. Sci., 24(1): 47-51.
16. Feroz Z, Khan RA, Afroz S (2011). Adverse effects of antiepileptic, antihypertensive, antidiabetic and antiarrhythmic drugs on hematological and hepatic parameters. Lat. Am. J. Pharm., 30 (2): 229-236.
17. Friedwald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, with out use of ultracentrifuge. Clin. Chem., 18: 499-502.
18. Gailani D, Renne T (2007). Intrinsic pathway of coagulation and arterial thrombosis. Arterioscl. Throm. Vas., 27: 2507-2513.
19. Janbaz KH, Gilani AH (2000). Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia, 71(1): 25-33.
20. Ko W, Yao X, Lau C, Law W, Chen Z, Kwok W, Ho K, Huang Y (2000). Vasorelaxant and antiproliferative effects of berberine. Eur. J. Pharmacol., 399(2-3): 187-196.
21. Kulkarni SK, Dhir A (2007). Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur. J. Pharmacol., 569(1-2): 77-83.
22. Lane DA, Philippou H, Huntington JA (2005). Directing Thrombin. Blood, 06: 2605-2612.
23. Musumeci R, Speciale A, Costanzo R, Annino A, Ragusa S, Rapisarda A, Pappalardo MS, Iauk L (2003). Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin. Int. J. Antimicrob. Ag., 22(1): 48-53.
24. Odetola AA, Iranloye YO, Akinloye O (2004). Hypolipidaemic potentials of solanum melongena and solanum gilo on Hypercholesterolemic Rabbits. Pakistan J. Nutr., 3(3): 180-187.
25. O'Hara M, Kiefer D, Farrell K, Kemper K (1998). A Review of 12 Commonly Used Medicinal Herbs. Arch. Fam. Med., 7(6): 523-536.
26. Orfao SC, Jank G, Mottaghy K, Walcher S, Zerz E (2008). Qualitative properties and stabilizability of a model for blood thrombin formation. J. Math. Anal. Appl., 346: 218-26.
27. Parmar C, Kaushal MK (1982). Berberis aristata. In: Wild Fruits. Kalyani Publisher, New Delhi, India, pp 10-14.
28. Qamar F, Afroz S, Feroz Z, Siddiqui S, Ara A (2011). Evaluation of hypoglycemic effect of cassia italica. J. Basic Appl. Sci., 7(1): 61-64.
29. Ross R (1999). Atherosclerosis-An Inflammatory Disease. N. Engl. J. Med., 340(2): 115-126.
30. Singh J, Kakkar P (2009). Anti hyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J. Ethnopharmacol., 123(1): 22-26.
31. Soffar SA, Metwali DM, Abdel-Aziz SS, El Wakil HS, Saad GA (2001). Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro. J. Egypt Soc. Parasitol., 31(3): 893-904.
32. Srivastava SK, Rai V, Srivastava M, Rawat AKS, Mehrotra S (2006). Estimation of heavy metals in different Berberis Species and Its Market Samples. Environ. Monit. Assess., 116: 315-320.
33. Tousoulis D, Davies G, Ambrose J, Tentolouris C, Stefanadis C, Toutouzas P (2002). Effects of lipids on thrombotic mechanisms in atherosclerosis. Int. J. Cardiol., 86(2-3): 239-247.
34. Trinder P (1969). Enzymatic colorimetric determination of triglycerides by GPO-PAP Method, Ann. Clin. Biochem., 6: 24-27.
35. Vaidya ADB (2006). Reverse pharmacological correlates of ayurvedic drug actions. Indian J. Pharmacol., 38(5): 311-315.